Stay up-to-date on current diabetes themes, proven therapeutic options, and knowledge resources and tools for you and your patients, and find detailed information on Novo Nordisk diabetes products.
Since the launch of its first pen needle in 1985, Novo Nordisk has been committed to enhancing injection experience
by putting technology in patient hands. NovoFine® Plus is the latest example of that commitment.
We have products for rare bleeding disorders, growth hormone-related disorders, and women’s health.
Chronic Weight Management
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
We are world leaders in diabetes care with a growing business in other treatment areas like haemophilia. We are more than 39,000 employees in 75 countries. Join us!
Most requests are reviewed within two weeks. Please contact GLIA@novonordisk.com or Cindy at 609-987-5297 for assistance.
You must fill in all required fields marked with *. Please correct.
Your email has been sent successfully. Most requests are reviewed within 2 weeks. You will be notified of our decision via US mail.